Mustang Bio (MBIO) Projected to Post Quarterly Earnings on Monday

Mustang Bio (NASDAQ:MBIO) is anticipated to announce its earnings results before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter.

Mustang Bio Trading Down 4.5 %

Shares of MBIO opened at $1.48 on Friday. The firm has a market cap of $1.41 million, a PE ratio of -0.02 and a beta of 1.82. The firm has a fifty day simple moving average of $5.05 and a two-hundred day simple moving average of $9.56. Mustang Bio has a 1-year low of $1.46 and a 1-year high of $68.50.

Mustang Bio Company Profile

Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.